CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.493
NA - Nord America 4.482
AS - Asia 2.610
SA - Sud America 220
AF - Africa 82
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 11.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.446
CN - Cina 1.348
IT - Italia 1.161
GB - Regno Unito 1.144
SG - Singapore 862
SE - Svezia 424
RU - Federazione Russa 374
FR - Francia 349
IE - Irlanda 302
DE - Germania 240
FI - Finlandia 232
BR - Brasile 198
KR - Corea 72
VN - Vietnam 69
UA - Ucraina 57
HK - Hong Kong 56
EG - Egitto 47
NL - Olanda 46
BE - Belgio 41
IR - Iran 31
ID - Indonesia 30
IN - India 27
TR - Turchia 25
AU - Australia 22
JP - Giappone 21
CA - Canada 20
CZ - Repubblica Ceca 18
CH - Svizzera 17
ES - Italia 14
AT - Austria 13
TG - Togo 12
MK - Macedonia 11
PK - Pakistan 11
GR - Grecia 9
IL - Israele 8
CL - Cile 7
EU - Europa 7
DK - Danimarca 6
JO - Giordania 6
MA - Marocco 6
NO - Norvegia 6
EC - Ecuador 5
LV - Lettonia 5
SA - Arabia Saudita 5
SD - Sudan 5
BD - Bangladesh 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
MX - Messico 4
PL - Polonia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
CY - Cipro 3
PA - Panama 3
PT - Portogallo 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AR - Argentina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
IQ - Iraq 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
VE - Venezuela 2
BO - Bolivia 1
BY - Bielorussia 1
GE - Georgia 1
IM - Isola di Man 1
KZ - Kazakistan 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
Totale 11.920
Salva come PNG Salva come JPEG
Città #
Southend 987
Chandler 786
Singapore 513
Ashburn 450
Woodbridge 382
Ann Arbor 374
Jacksonville 331
Dublin 302
Beijing 245
Verona 212
Houston 148
New York 142
Wilmington 126
Lawrence 122
Princeton 122
Jinan 109
Nanjing 102
Helsinki 101
Hebei 88
Shenyang 88
Milan 81
Boardman 70
Washington 55
Hong Kong 48
The Dalles 46
Tianjin 44
Dong Ket 43
Lancaster 43
Zhengzhou 43
Redwood City 42
Brussels 41
Changsha 40
Ningbo 40
Haikou 37
Nanchang 37
Hangzhou 36
Rome 36
Redmond 35
Los Angeles 30
Taiyuan 30
Jakarta 29
Sindelfingen 28
Taizhou 28
Guangzhou 25
Bologna 24
Cairo 24
Dallas 24
Seattle 24
Seoul 22
Fuzhou 21
Santa Clara 21
Dearborn 20
Falls Church 20
Tehran 20
Jiaxing 19
Norwalk 18
Padova 18
Naples 16
Council Bluffs 15
Olomouc 15
Catania 14
Clearwater 13
Columbus 13
Lanzhou 13
Moscow 13
Nuremberg 13
Shanghai 13
Florence 12
Lomé 12
Tokyo 12
Düsseldorf 11
Kent 11
Seongbuk-gu 11
Skopje 11
Amsterdam 10
Auburn Hills 10
Brescia 10
Plymouth 10
Riva 10
São Paulo 10
Tappahannock 10
Athens 9
Belo Horizonte 9
Fairfield 9
Kemerovo 9
Bari 8
Dongguan 8
Genoa 8
London 8
Al Mansurah 7
Bisenti 7
Bolzano 7
Bronte 7
Frankfurt am Main 7
Lappeenranta 7
Loreggia 7
Melbourne 7
Paris 7
Amman 6
Ancona 6
Totale 7.423
Salva come PNG Salva come JPEG
Nome #
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 445
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 385
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 207
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 183
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 180
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 148
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 145
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 142
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 135
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 134
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 130
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 128
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 128
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 127
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 124
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 123
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 122
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 122
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 121
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 121
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 119
Cognitive onset in multiple sclerosis 117
Risk factors for post-polio syndrome among an Italian population: a case-control study. 116
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 114
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 114
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 112
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 110
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 109
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 108
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 108
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 108
A case of acute fulminant multiple sclerosis treated with alemtuzumab 106
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 105
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 105
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 105
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 104
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 103
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 102
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 101
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 99
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 99
HCV-related nervous system disorders. 98
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 97
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 97
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 97
Epilepsy in multiple sclerosis: The role of temporal lobe damage 97
Response to Nagai et al. 96
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 95
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 95
Brentuximab vedotin: axonal microtubule's Apollyon 95
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 95
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 94
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 94
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 94
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 92
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 91
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 90
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 90
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 90
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 90
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 88
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 88
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 87
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 87
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 87
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 87
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 87
Amyloid myopathy: an intriguing diagnosis 87
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 84
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 84
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 84
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 84
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 83
Long survival and clinical stability in Marburg's variant multiple sclerosis. 83
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 82
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 82
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 82
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 81
Prognostic factors of acute partial transverse myelitis. 80
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 79
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure 78
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 78
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 77
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 74
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 74
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 73
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 73
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 72
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 70
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 70
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 70
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. 69
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 69
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 69
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 68
Impact of switching first-line disease-modifying therapy after treatment failure in relapsing-remitting multiple sclerosis 67
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 67
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 67
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 67
Tumor-like multiple sclerosis: three cases misdiagnosed as primary brain neoplasm 66
Totale 10.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.342
article - articoli 40.678
book - libri 0
conference - conferenze 1.431
curatela - curatele 0
other - altro 316
patent - brevetti 0
selected - selezionate 0
volume - volumi 917
Totale 86.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020307 0 0 0 0 0 0 0 0 0 114 91 102
2020/20211.169 142 223 79 116 137 103 28 41 65 35 104 96
2021/20221.177 98 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20252.375 169 200 201 486 174 148 188 178 478 153 0 0
Totale 12.136